completes
Eisai
Sports
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM)...
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) IQLIK(TM) (lecanemabirmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose...





